Aurinia Pharmaceuticals Inc vs. Eli Lilly & Co.
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AUPH | LLY | |
|---|---|---|
| Market Cap | $2.06 billion | $1.09 trillion |
| Revenue (TTM) | $311.51 million | — |
| Net Income (TTM) | $314.11 million | — |
LLY leads on 1 of 1 size & scale factors.
Valuation
| AUPH | LLY | |
|---|---|---|
| P/E Ratio | 6.76 | — |
| Price / Book | 3.34 | — |
| Price / Sales | 6.60 | — |
AUPH and LLY split the valuation factors evenly.
Profitability
| AUPH | LLY | |
|---|---|---|
| Net Margin | 100.84% | — |
| Return on Equity | 51.09% | — |
AUPH and LLY split the profitability factors evenly.
Risk & Sentiment
| AUPH | LLY | |
|---|---|---|
| Short Interest | 7.43% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: AUPH overview, AUPH financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.